Mavrilimumab Antibody is a research-grade biosimilar monoclonal antibody targeting CD116. It is a human IgG4-lambda2 antibody. Reactivity: Human. Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.
Granulocyte-macrophage colony-stimulating factor receptor subunit alpha (CD116/CSF2RA) is a ~46 kDa protein. Low affinity receptor for granulocyte-macrophage colony-stimulating factor. Transduces a signal that results in the proliferation, differentiation, and functional activation of hematopoietic cells.
Product Name:
Mavrilimumab Antibody
SKU:
GXBS00169
Size:
100 µg, 1 mg
Antibody Type:
Monoclonal Antibody
Target:
CD116
Isotype:
IgG4-lambda2
Host Species:
Human
Reactivity:
Human
Applications:
ELISA, FCM, Functional assay, Research in vivo
Expression Host:
Mammalian cells
Synonyms:
CAM-3001, 1085337-57-0
Purity:
>95% as determined by SDS-PAGE.
Endotoxin Level:
< 10 EU/mg
Formulation:
0.01M PBS pH 7.4.
State of Matter:
Liquid
Regulatory Status:
For research use only. Not suitable for clinical or therapeutic use.
Product Preparation:
Protein A/G purified from cell culture supernatant.
Storage and Handling:
Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
